Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.

Melief SM, Visser M, van der Burg SH, Verdegaal EME.

Cancer Immunol Immunother. 2017 Jul;66(7):913-926. doi: 10.1007/s00262-017-1995-x. Epub 2017 Apr 11.

2.

Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature.

Melief SM, Visconti VV, Visser M, van Diepen M, Kapiteijn EH, van den Berg JH, Haanen JB, Smit VT, Oosting J, van der Burg SH, Verdegaal EM.

Cancer Immunol Res. 2017 Feb;5(2):170-179. doi: 10.1158/2326-6066.CIR-16-0288. Epub 2017 Jan 10.

3.

The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2-4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches.

Melief SM, Visconti VV, Doorduijn EM, Santegoets SJ.

Cancer Immunol Immunother. 2014 Oct;63(10):1105-12. doi: 10.1007/s00262-014-1532-0. Epub 2014 Mar 12. No abstract available.

PMID:
24619351
4.

Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules.

Melief SM, Geutskens SB, Fibbe WE, Roelofs H.

Haematologica. 2013 Sep;98(9):e121-2. doi: 10.3324/haematol.2013.093864. No abstract available.

5.

Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages.

Melief SM, Schrama E, Brugman MH, Tiemessen MM, Hoogduijn MJ, Fibbe WE, Roelofs H.

Stem Cells. 2013 Sep;31(9):1980-91. doi: 10.1002/stem.1432.

6.

Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H.

Stem Cells Transl Med. 2013 Jun;2(6):455-63. doi: 10.5966/sctm.2012-0184. Epub 2013 May 21.

7.

Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.

Melief SM, Geutskens SB, Fibbe WE, Roelofs H.

Haematologica. 2013 Jun;98(6):888-95. doi: 10.3324/haematol.2012.078055. Epub 2013 Jan 24.

8.

Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.

Maijenburg MW, Gilissen C, Melief SM, Kleijer M, Weijer K, Ten Brinke A, Roelofs H, Van Tiel CM, Veltman JA, de Vries CJ, van der Schoot CE, Voermans C.

Stem Cells Dev. 2012 Jan 20;21(2):228-38. doi: 10.1089/scd.2011.0076. Epub 2011 Jun 1.

Supplemental Content

Loading ...
Support Center